the diverse progenitors that give rise to the human neocortex have been difficult to characterize because progenitors, particularly radial glia (rG), are rare and are defined by a combination of intracellular markers, position and morphology. to circumvent these problems, we developed Fixed and recovered intact single-cell rnA (Friscr), a method for profiling the transcriptomes of individual fixed, stained and sorted cells. using Friscr, we profiled primary human rG that constitute only 1% of the midgestation cortex and classified them as ventricular zone−enriched rG (vrG) that express AnXA1 and crYAB, and outer subventricular zone−localized rG (orG) that express hoPX. our study identified vrG and orG markers and molecular profiles, an essential step for understanding human neocortical progenitor development. Friscr allows targeted single-cell profiling of any tissues that lack live-cell markers.
bias in mRNA detection as assessed by quantitative reversetranscriptase PCR (qRT-PCR); we detected high correlations between live and fixed cells for every gene tested (Fig. 2c) . We sought to extend this technique to single cells by improving mRNA recovery. Oligo dT25 beads gave better recovery and could be eluted in low volumes after purifying RNA from the reverse cross-linking buffer (Supplementary Fig. 1c) . The low volume allowed us to apply the entire sample directly to the SmartSeq2 RNA sequencing reaction.
We called this method FRISCR (Fig. 3a) . To evaluate our approach, we sorted live or fixed H1 hESCs and prepared mRNA by either standard Triton X-100 lysis (TL) or FRISCR. Sequencing library preparation gave comparable amounts of cDNA from individual fixed and live cells ( Fig. 3b and Supplementary Fig. 2 ), and sequencing (subsampled to five million total reads) produced read alignments that were poor for fixed cells prepared with TL, indicative of much lower mRNA input, or comparable to those with live cells when prepared using FRISCR ( Fig. 3c and Supplementary  Fig. 2 ). The frequency of reads mapping to different transcript classes and number of genes detected per cell was also similar between live and fixed cells prepared using FRISCR ( Fig. 3c and Supplementary Fig. 2a,c) . Reads across all genes showed a similar 3′ to 5′ bias (Fig. 3d) ; however, fixed cells showed an increased 3′ read bias with longer transcripts (Supplementary Fig. 2g ). Spearman correlations of the expression of all genes did not discriminate live from fixed cells (Fig. 3e) , and expression of only two genes in the genome was differentially detected between sets of single cells ( Fig. 3f and Supplementary Fig. 3 ).
Analysis of External RNA Controls Consortium (ERCC) spike-in mRNAs showed similar linear mRNA amplification by TL and FRISCR ( Supplementary Fig. 2d ), but TL samples showed moderately higher estimated sensitivity compared to FRISCR, recovering ~25% versus ~16% of transcripts, respectively ( Supplementary Fig. 2e ). Nevertheless, FRISCR-and TL-generated single-cell libraries were not separated when clustered by Spearman correlations (Fig. 3e) , and just over 30 genes were differentially expressed between the two methods, of which many are noncoding or irregularly polyadenylated ( Fig. 3f and Supplementary Fig. 3 ) 19 . No method showed major changes in G+C coverage, chromosomal transcript representation bias ( Supplementary Fig. 2h ,i) or rates of alignment to mRNA (Fig. 3c) . We detected a subtle increase in the mutation rate in FRISCR-prepared live cells, but preparation using FRISCR substantially reduced the mutation rate of fixed cells compared to preparation with standard TL (Supplementary Fig. 2f ).
Friscr profiling of primary rG diversity
We leveraged the ability of FRISCR to profile rare and unmarked cell types by examining the diversity of RG progenitors from primary fetal human cortex. Fig. 4a ). Although RG and IPC progenitors are enriched in the germinal zones, they are rare when the entire cortical thickness is prepared: 3.2 ± 0.9% (mean ± s.d.) of cells were SOX2 + PAX6 + , and this population was further divided into EOMES + cells (SPE; 2.1 ± 0.6%) and EOMES − cells (SP; 1.0 ± 0.3%) ( Fig. 4a and Supplementary  Fig. 4a ). We then amplified cDNA from 207 SP cells and 48 SPE cells using SmartSeq2 (ref. 20) . Primary cells showed more lowmolecular-weight cDNA than hESCs ( Fig. 3b and Supplementary  Fig. 5 ), perhaps indicating some RNA degradation due to ≥4 h postmortem intervals in these clinical specimens.
We sequenced single-cell libraries at low read depth on the MiSeq (Illumina) (Supplementary Table 1 and Supplementary  Data 1 and 2) . Read alignment proportions were consistent in all but a few cells, which may have displayed poor mapping owing to primer dimers or contaminating dead cells (Supplementary Fig. 5c ). We included in the analysis libraries with more than 10,000 mapped reads, >20% reads mapping to mRNA and detectable GAPDH expression (157 SP and 29 SPE cells; Supplementary Fig. 5d and Supplementary Table 1) . We detected ~3,000−4,000 unique genes per progenitor cell ( Supplementary  Fig. 5e ), similar to an independent study of live prenatal human single cells 21 . As expected, PAX6 and SOX2 were expressed in most SP and SPE cells, and EOMES mRNA was enriched in SPE versus SP cells (86% and 22%, respectively; Fig. 4b) . Principal-component analysis and hierarchical clustering of genes with variance above technical noise demonstrated SP cells partitioning away from SPE cells independently of read depth, cortical sample or mapping percentage, despite the low read depth and partial sample degradation ( Supplementary Fig. 5f,g ). We did not observe this partition after correlation with all expressed genes or with only ERCC spike-in RNA reads (Supplementary Fig. 5g) . Lastly, our cells clustered with previously identified RG and IPCs profiled from an independent study on live human cortical cells (Supplementary Fig. 6a ) 21 , and largely lacked expression of common contaminating cell markers (Supplementary Fig. 6b ). Our data demonstrate that FRISCR can be used to profile rare primary human neuronal progenitors.
The fact that we profiled an order of magnitude more RG and IPCs than had been done in previous transcriptomic studies 21 npg allowed us to characterize progenitor heterogeneity. We identified five modules of coexpressed genes from high-variance genes by weighted gene coexpression network analysis (WGCNA) 22 ( Fig. 5a and Supplementary Fig. 7 ). We excluded two modules from clustering that contained many cell cycle−related genes; these modules were enriched in SPE cells, which are twice as likely to be in S−G 2 −M phase ( Supplementary Fig. 4b ). We used genes populating the five WGCNA modules to group cells into six clusters labeled A−F (Fig. 5a,b and Supplementary Fig. 8 ), all but one containing cells from each cortical tissue. Module 1 reflected the division of the majority of RG from IPC cells, and contained canonical markers of RG including VIM, and of IPCs including EOMES, HES6 and NEUROG1 ( Fig. 5a and Supplementary Fig. 7 ). Modules 2−5 revealed four RG subpopulations as seen by module eigengene values (Fig. 5a) . Cluster E cells were enriched for module 3 genes including immediate early genes EGR1 and FOS 21 , and the genes CXCL12, ANXA1 and CYR61 ( Supplementary Figs. 7 and 8) . Flow cytometry confirmed that a substantial number of SP cells, but few SPE cells, stained positively for CYR61 (Supplementary Fig. 9 ). A subset of cluster E cells also expressed many genes in module 5 ( Supplementary Figs. 7 and 8) . Cells in clusters C and D expressed higher levels of module 2 and 4 genes than other cell clusters did, but not of module 3 and 5 genes. Module 2 is composed of genes such as FAM107A, HOPX and SLCO1C1; and module 4 genes were enriched specifically in cluster C cells. These analyses revealed molecular diversity within the human RG compartment that had not been previously appreciated to our knowledge.
new markers distinguish vrG and orG cells
To further characterize this diversity, we compared RG gene expression signatures to data in anatomical atlases. The module 2 and 4 eigengenes were enriched in the oSZ relative to the ventricular zone in 21 PCW cortex (unpaired t-test, P = 6.3 × 10 −11 for module 2 and P = 1.5 × 10 −19 for module 4) but not at earlier time points in the BrainSpan Atlas of the Developing Human Brain 11 ( Fig. 5c and Supplementary Fig. 10 ). The module 3 eigengene was enriched in the ventricular zone at all time points (P = 3.9 × 10 −15 , P = 6.2 × 10 −12 , and P = 7.8 × 10 −10 for 15, 16, and 21 PCW tissues), whereas module 5 was significantly enriched only in the ventricular zone in 21 PCW tissue (P = 4.1 × 10 −6 ; Fig. 5c and Supplementary Fig. 10a ). Strong HOPX expression initiates around embryonic day 70 in macaque according to the NIH Blueprint Non-Human Primate Atlas, coinciding with the emergence of the oSZ 23 (Supplementary Fig. 10c ). Thus, we hypothesize that vRG express module 3 and module 5 genes, whereas oRG express module 2 and module 4 genes 3, 4 .
To test the distinction between vRG and oRG cells, we identified genes enriched in modules 2 or 3 that were also differentially expressed between the ventricular zone and the oSZ regions in the 21 PCW BrainSpan Atlas data. We identified ten genes enriched in both the FRISCR-prepared vRG cells and the 21 PCW ventricular zone, and nine genes enriched both in FRISCR-prepared oRG cells and the 21PCW oSZ ( Fig. 5d and Supplementary Fig. 10b ). The canonical progenitor markers SOX2, PAX6, EOMES and HES1 were expressed at similar levels in both germinal zone npg regions (Fig. 5d) . We confirmed several genes that marked vRG and oRG cells with antibody staining of human cortical sections (Fig. 6a) . CRYAB and ANXA1 showed signal only in the ventricular zone (except for vascular staining), whereas oRG markers HOPX and F3 (encoded by module 2 genes) showed high expression in the oSZ and iSZ, but faint signal in the ventricular zone of a 15 and 16 PCW cortex ( Fig. 6a and Supplementary Figs. 9b and 11) . We used SOX2 to mark RG, as nearly all SOX2 + cells were PAX6 + in the germinal zones (Supplementary Fig. 12a ). HOPX + SOX2 + cells in the ventricular zone occasionally exhibited apical process anchored at the ventricular surface at 16 PCW (Fig. 6b) , and in the oSZ often displayed basally directed processes as assessed by phospho-Vimentin or HOPX staining (Fig. 6c,d and Supplementary Fig. 11b ). At later developmental stages such as 19 and 21 PCW, we detected HOPX exclusively in the oSZ and almost never in the ventricular zone by gene expression (Fig. 5d and Supplementary Fig. 10b) , and HOPX by antibody staining (Fig. 6d and Supplementary  Fig. 11a ). HOPX + oRG and ANXA1 + vRG were proliferative because 17% of HOPX + SOX2 + cells and 28% of ANXA1 + SOX2 + cells were also positive for Ki67 (Fig. 6e,f and Supplementary  Fig. 11c ). The majority of oRG progenitors were marked by HOPX: more than 78% of SOX2 + cells in the oSZ co-stained with HOPX, and less than 1% of HOPX + cells in the oSZ were SOX2 − (Fig. 6g) . In contrast, 85% of SOX2 + cells in the ventricular zone were ANXA1 + , and only 2% of ANXA1 + cells in the ventricular zone lacked SOX2 expression (Fig. 6h) . Module 2 genes such as HOPX and module 3 genes such as ANXA1 are thus robust diagnostic markers for human mid-gestation oRG and vRG. Multiplexing these markers reveals distinct new progenitor populations in the developing human cortex for further analysis ( Fig. 6i and Supplementary Fig. 12b−e) . Mouse HOPX expression is restricted to the medial cortex 24 , while we detected human HOPX protein and gene expression throughout the human developing cortical germinal zones (Supplementary Fig. 13 ). This suggests HOPX expression has changed through evolution. Study of these progenitors will help reveal molecular changes that underpin cortical evolution. discussion FRISCR is the first method, to our knowledge, that enables targeted mRNA purification and single-cell transcriptomic profiling of fixed cells without compromising data quality compared with live cells. FRISCR has three important advantages over current single-cell profiling methods. First, it allows enrichment of rare cell populations without live-cell markers. Without enrichment, we would have needed to profile 20,000 cortical cells to obtain data from 200 SP cells. Enrichment is particularly valuable for primary human tissues that are genetically inaccessible, or for which live-cell markers are unknown or poorly validated. Second, intracellular markers can be multiplexed with genetic reporters or other marking strategies to prospectively isolate and profile precisely defined cell types. Third, the FRISCR procedure allows npg fixed cells to be stored indefinitely at −80 °C (and easily transported), unlike current protocols that require sorting of cells on the same day as tissue harvesting. Future optimizations will streamline sample processing and could allow both genome and transcriptome sequencing from the same fixed and sorted cell 25 or single-cell profiling of cells marked by FISH probes 15, 26 . We demonstrated that FRISCR can be applied to investigate the composition of human neocortical progenitors. Several studies have analyzed differential gene expression or co-expression in microdissected germinal zones including the oSZ 10, 11, 27 . Although those studies had revealed new RG gene networks, they did not identify distinct oRG markers, likely because the cell type makes up a minority of the sample population. Two recent studies have set out to profile human RG progenitors in single cells. To enrich for cortical progenitors, the authors of the first study had sorted live cells based on CD133 expression and DiI labeling to mark apical (including vRG) and basal progenitors (excluding vRG but including oRG) 12 . ARHGAP11B had been identified and shown to regulate human progenitor dynamics. However, only the apical progenitors expressed PAX6 and both populations expressed high levels of EOMES. Thus, the apical compartment defined by the study likely contained IPCs and RG, whereas the basal compartment likely lacks RG owing to the absence of PAX6. We did not detect ARHGAP11B expression in RG or IPC cells, indicating that this gene likely has a role in different cell types or stages. The second study used differential CD133, GLAST and CD15 staining to enrich and profiled vRG or oRG 13 . NEUROG2 had been identified as a regulator of oRG cells 13 . High EOMES expression had been detected in both vRG and oRG, similar to the first study. We detected only low expression of NEUROG2 in our RG cells and much higher expression in our IPCs, suggesting that the population of oRG in ref. 13 best corresponds to our IPCs, which also express HES6 and EOMES. Those studies 12, 13 did not detect our validated and new vRG-or oRG-specific markers. Together these observations strongly suggest our study is to our knowledge the first to isolate and accurately profile these cells at the transcript and single-cell level. While our paper was in press, a study that profiled single cells from microdissected human germinal zone reported vRG-and oRG-specific gene markers that overlap substantially with our study (including CRYAB and HOPX, respectively) 28 . This provides independent confirmation that vRG and oRG cells can be distinguished using our new molecular markers.
Our results lay a foundation for the study of human RG diversity, maturation and fate. Using FRISCR, we discovered markers for human vRG and oRG, some of which appear likely to regulate RG self-renewal and differentiation. HOPX, a transcriptional regulator and oRG marker, shows divergent expression between mouse and human developing cortex 24 , and may illuminate differences between the two species. HOPX is expressed in adult neurogenic progenitors in the hippocampus as well as self-renewing multipotent progenitors in the intestine, skin and certain cancers [29] [30] [31] [32] [33] where it functions by suppressing immediate early response genes 33, 34 . Thus, the expansion of the human oSZ compartment in evolution could involve the reuse of existing mechanisms that control stem cell homeostasis in different tissues. Indeed, HOPX was recently shown to mark restricted cardiomyocyte progenitors, and to modulate their fate through the integration of niche BMP and WNT signals 35 , pathways that are also thought to underpin corticogenesis 27, 36 . Future work can focus on characterizing the origins of mid-gestation vRG and oRG cells, and determining whether they maintain neurogenic potential or have become glial-restricted 8, 37, 38 . Unraveling the fates of these progenitors and their regulatory mechanisms is central to understanding how the human brain is formed and has evolved. methods Methods and any associated references are available in the online version of the paper.
Accession codes. Gene Expression Omnibus: GSE71858 (H1 hESC data). dbGaP: phs001016.v1.p1 (human single-cell data). Data from donor H14.4010 is available upon request. online methods Cell isolation from fetal cortex. We acquired tissue from the Birth Defects Research Laboratory (BDRL) at the University of Washington, who obtained appropriate written informed consent and provided available nonidentifying information for each sample. The Human Subjects Division at the University of Washington approved tissue acquisition, which was performed according to the requirements of the Uniform Anatomical Gift Act and National Organ Transplant Act for the acquisition of human tissue for biomedical research purposes. Fetal age was determined by foot length and date of last menses.
We divided cortical pieces into one half for fixation, sectioning and immunocytochemistry staining, and the other half for cell isolation. For dissociation, we minced the tissue into small pieces (~0.25−0.5 ml volume) with #5 forceps (Fine Science Tools) in Ca 2+ -free and Mg 2+ -free HBSS (14175-095, Life Technologies). We treated minced pieces with 2 ml trypsin solution for 20 min at 37 °C (Ca 2+ -free and Mg 2+ -free HBSS, 10 mM HEPES, 2 mM MgCl 2 , 0.25 mg/ml bovine pancreatic trypsin (EMD Millipore), 10 µg/ml DNase I (Roche), pH 7.6, 100 nM TTX (Tocris, 1069), 20 µM DNQX (Tocris, 0189) and 50 µM DL-AP5 (Tocris, 3693)). We quenched digestion with 6 ml of ice-cold quenching buffer (440 ml Leibovitz L-15 medium, 50 ml water, 5 ml 1M HEPES pH 7.3-7.4, 5 ml 100× penicillin-streptomycin, 2 mg/ml bovine serum albumin (A7030, Sigma), 100 µg/ml trypsin inhibitor (T6522, Sigma), 10 µg/ml DNase I, 100 nM TTX, 20 µM DNQX, and 50 µM DL-AP5). We then pelleted the samples (220g, 4 min, 4 °C) and resuspended with 1 ml of quenching buffer and triturated on ice with a 1-ml pipette set to 1 ml, using 25 gentle cycles up and down without forming bubbles. We then diluted the cell suspension to 30 ml in Staining Medium (440 ml Leibovitz L-15 medium, 50 ml water, 5 ml 1 M HEPES pH 7.3-7.4, 5 ml 100× penicillin-streptomycin, 20 ml 77.7 mM EDTA pH 8.0 (prepared from Na 2 H 2 EDTA), 1 g bovine serum albumin, 100 nM TTX, 20 µM DNQX, and 50 µM DL-AP5), filtered through a 45 µm cell filter, pelleted (220g, 10 min, 4 °C), resuspended in 5 ml staining medium, and counted on a hemocytometer (typically ~30-50 million live cells isolated per cortical piece at ~50% viability).
Cell isolation from culture. We maintained H1 hESCs (WiCell) on Matrigel (Corning) in mTESR1 media (StemCell Technologies), authenticated them by karyotype analysis (Cell Line Genetics), and periodically tested them for sterility and mycoplasma contamination (IDEXX BioResearch). We dissociated adherent cultures with StemPro Accutase Cell Dissociation Reagent (Life Technologies), and then centrifuged the cells (220g, 3 min) and the dissociation solution was removed.
FRISCR. Cell wash. We washed then resuspended the cells in RNase-free staining buffer (SB) (1× PBS pH 7.4, 1% RNase-free BSA (Gemini Bioproducts), and 0.0025% RNasin Plus (Promega)). We placed cells on ice until fixation or sorting.
Fixation. We fixed the single cell suspension with 4% PFA (Electron Microscopy Sciences) in PBS on ice for 15 min, then pelleted them (335g, 3 min, 4 °C), washed them once with 1 ml SB, then resuspended the cells in SB at 10 million cells/ml, and froze them at −80 °C in aliquots.
Permeabilization and staining. We thawed and permeabilized the cells by resuspending and incubating for 10 min on ice in 1× PBS, 0.1% Triton X-100 (Sigma), 1% BSA, 0.0025% RNasin Plus. We incubated one million cells in SB (1× PBS, 1% BSA, 0.0025% RNasin Plus) with primary antibodies for 30 min at 4 °C. Antibodies used were: Alexa Fluor 488− or PE-conjugated anti-PAX6 (O18-1330; BD Biosciences), PEconjugated anti-DCX (30/Doublecortin; BD Biosciences), PerCP-Cy5.5-conjugated anti-SOX2 (O30-678; BD Biosciences), eFluor660-conjugated anti-EOMES (WD1928; eBioscience), rabbit anti-CYR61 (D4H5D; Cell Signaling Technology) followed by PE-conjugated goat anti-rabbit IgG (Life Technologies). We washed cells in SB, resuspended them in SB containing 1 µg/ml DAPI (Life Technologies), and filtered before sorting.
Single-cell sorting. We carried out cell sorting on a BD FACS ARIA-II SORP (BD Biosciences) using a 130 µm nozzle. We sorted single cells into strip tubes containing 5 µl of PKD buffer (Qiagen) with 1:16 proteinase K solution (Qiagen) and ERCC spike-in synthetic RNAs (Life Technologies).
Cell lysis, reverse crosslinking and RNA purification. To lyse cells and purify RNA with dT25 beads, we thawed samples at 25 °C, room temperature (RT), mixed them, and then incubated at 56 °C for 1 h in a thermal cycler with the lid set at 66 °C. We vortexed cells for 10 s, spun them down, and placed them on ice. We prepared oligo dT25 magnetic beads (Life Technologies) with three washes of 1× hybridization buffer (2 × SSPE, 0.05% Tween 20, 0.0025% RNasin Plus) and then resuspended in half of the original volume of 2× hybridization buffer. 5 µl of washed dT25 beads (0.05 mg of beads) were used per reaction.
We added beads to reverse crosslinked samples and then heated to 56 °C for 1 min, incubated at RT 10 min to allow mRNA hybridization, and then placed mixtures on ice. We washed beads two times in 100 µl of ice-cold hybridization buffer, followed by a subsequent wash using ice-cold 1× PBS, 0.0025% RNasin Plus. We removed PBS and added 2.8 µl of RNase-free water, then resuspended the beads and incubated the mixture at 80 °C for 2 min to elute mRNA, then immediately pelleted on a room temperature magnet. We rapidly removed the supernatant containing mRNA, transferred it to a new tube and stored it at −80 °C.
RNA extraction from populations of cells. Sorting. We sorted cells as described above. We sorted populations up to 1,000 cells into 1.5 ml tubes with 100 µl of PKD solution. We sorted 10,000 cell samples into 1.5 ml tubes containing 500 µl of SB, pelleted them, and resuspended the cells in 100 µl of PKD solution.
Cell lysis, reverse cross-linking and RNA purification. We purified total RNA using either the standard live-cell methods from the RNeasy Micro Kit (RLT method) or a modified protocol for fixed cells using the miRNeasy FFPE Kit (Qiagen) (protease lysis, reverse cross-linking method (PLRC)). For the PLRC method, we thawed cells in 100 µl of PKD with Proteinase K solution at RT, mixed the samples, and incubated them at 56 °C for 1 h. Samples were then centrifuged at 20,000g for 20 min. We transferred the supernatant to a new tube and added 10 µl of DNase booster buffer (a component of the Qiagen RNeasy kit) and 10 µl of DNase I stock solution and mixed by inversion. Then we incubated samples 15 min at RT then added 320 µl of RBC buffer and 1,120 µl of ethanol and mixed. Finally, we applied the samples to MinElute columns, washed twice with 500 µl RPE Buffer, and eluted RNA into 15 µl of water. We evaluated nAture methods and quantified RNA on a Bioanalyzer 2100 (Agilent) using the RNA Pico Kit. To normalize input, we used 1 µl directly from 1,000 cells, 1 µl of tenfold diluted RNA from 10,000 cells, or 1 µl of tenfold concentrated RNA from 100 cells (Savant DNA 120 SpeedVac).
SmartSeq2
. We prepared sequencing libraries as previously reported 20 . After reverse transcription and template switching, we amplified cDNA with KAPA HotStart HIFI 2× ReadyMix (Kapa Biosystems) for 19 or 22 cycles for RNA from single hESC or cortical progenitor cells, respectively. We purified PCR products using Ampure XP beads (Beckman Coulter). We quantified cDNA using a High Sensitivity DNA Chip (Agilent) on a Bioanalyzer 2100, or with the Quant-iT PicoGreen dsDNA Assay Kit (Life Technologies) on an Enspire plate reader (PerkinElmer). We used 1 ng of cDNA to generate RNA-seq libraries using the Nextera XT library prep system (Illumina). Single cells from primary tissue contained a lower amount of mRNA compared to H1 hESCs, requiring a reduction in ERCC spike-in RNAs by tenfold and addition of three extra PCR cycles. We carried out sequencing of human cortical progenitors on Illumina MiSeq using 31-base paired-end reads. We carried out sequencing of hESCs on the HiSeq using 50-base paired-end reads. We saw few global differences in read statistics between MiSeq runs and HiSeq runs when samples were assessed on both instruments.
RNA-seq data analysis. We aligned raw read data to GRCh37 (hg19) using the RefSeq annotation gff file downloaded on 23 April, 2013. We performed transcriptome alignment first using RSEM 39 , then we aligned unmapped reads to hg19 using Bowtie 40 , and then we aligned remaining unmapped reads to the ERCC sequences. Using a custom script we calculated the read mapping % of each cell to mRNA (RefSeq), mitochondrial RNA (mtRNA), noncoding RNA (mRNA NC), ribosomal RNA (rRNA), genome and ERCC RNA. We performed principal-component and clustering analysis using transcripts per million (TPM) values (log 2 -transformed). We used only high-variance genes with adjusted P < 0.05 and those that were present (mapped reads > 0) in more than ten cells for analysis. RSEM-generated gene count and TPM data from primary fetal human tissue is supplied as Supplementary Data 1 and 2, and raw data will be provided upon request. WGCNA analysis. We included only high variance genes based on DESeq2 with an adjusted P < 0.01 and expressed in at least five cells. We performed WGCNA clustering using soft power of four, cut height of 0.995, and minimum module size of ten. To filter gene modules, we used genes of each module to cluster cells into two clusters, and then evaluated to determine which of the module genes are differentially expressed between the two clusters. We removed a gene module if one of the two clusters contained less than five cells, or if the total differential score (−log 10 adjusted P value of differentially expressed genes) was less than 40. This filtering criterion eliminates gene modules driven by very small numbers of cells, and gene modules with little discriminating power. We also eliminated two gene modules corresponding to cell cycle states. We clustered cells using hclust based on filtered module genes and Ward's distance measure. After the initial clusters were determined, we detected differentially expressed genes between every pair of cell clusters using the Bioconductor limma package. The union of all such genes was defined as cluster-specific markers. We then reclustered the cells based on the marker genes using hclust to determine the final clusters.
3′ to 5′ bias analysis. To assess 5′ to 3′ read coverage bias, transcripts not alternatively spliced, and with TPM > 1 in at least 30 samples were selected. Each transcript was divided into 100 bins uniformly distributed across the transcript, and average read coverage within each bin was determined from only uniquely aligned reads (RSEM ZW score > 0.5). Data are shown as normalized average read coverage per bin for all genes or genes of a predicted length.
Mutational analysis. To detect mutations in each sample, we filtered alignment bam files to exclude reads with more than two errors or ambiguous mapping (RSEM ZW score < 0.95). Variance calling was performed by comparing reads to the reference genome using samtools mpileup followed by bcftools call 41 . We filtered detected mutations to exclude mutations within three base pairs of insertion or deletion mutations, with a quality score of < 10, depth of < 5 or an alignment mapping quality (MQ) score of < 50, using bcftools. We defined common variants as nucleotide changes where the variant is shared by more than 10 samples, and by more than two thirds of all samples that pass the quality filter threshold. The mutation rate for each sample is defined as non-common variant mutations divided by the number of genomic positions that pass the above-mentioned filter.
G+C and chromosomal bias analysis. To assess the G+C bias between TL-and FRISCR-prepared live and fixed single hESCs, we pooled genes into ten equally sized bins based on percentage G+C content. For each bin, we calculated the fraction of the genes detected in each sample out of all annotated genes. To test for any chromosomal bias, we binned genes by their chromosomal locations. We calculated the fraction of the genes detected in each sample out of all annotated genes for each chromosome.
Human Atlas comparisons. For the BrainSpan Atlas of the Developing Human Brain 11 laser capture microdissection (LCM) microarray data sets eigengene expression was determined using the same gene modules described above. In both data sets we compared side-by-side a subset of genes differentially expressed between ventricular zone (VZ), iSZ and oSZ and differentially expressed between cell clusters C and D (oRG cells) versus cell cluster E (vRG cells) (Fig. 5d) . We determined the statistical significance of eigengene enrichment in human LCM data by unpaired t test comparing the VZ and the oSZ.
Tissue immunocytochemistry. We fixed cortical tissue sections by immersion in 4% paraformaldehyde in PBS for 24 h at 4 °C. We washed tissue in PBS, then transferred to and stored in 30% sucrose in PBS (Sigma) for 2 days (or until tissue sank). We embedded tissue in Tissue-Tek O.C.T (Sakura Finetek) and npg Statistics. Sample inclusion/exclusion. For analysis of RNA from populations of hESCs ( Fig. 2 and Supplementary Fig. 1a) , we sorted four cell samples per condition/number on three independent days (12 total samples per condition/number) for the 10,000-and 1,000-cell experiments, and we conducted two independent experiments for the 100-cell experiment (eight total samples per condition/number). Two outliers from both 1,000 hESC Live/PLRC and Fixed/PLRC samples were excluded from analysis because of process failure and no observed RNA. The Bioanalyzer was unable to call an RNA integrity number for one 10,000-cell Fixed/RLT sample, and one 100-cell Live/PLRC sample; and one 100-cell Live/PLRC, and Fixed/PLRC samples were lost due to mechanical failure.
For sequencing single hESCs (Fig. 3, and Supplementary  Figs. 2 and 3) , we sorted eight individual hESCs on two days of experiments for each condition (16 cells total per condition). Library generation failed for some cells, as judged by insufficient cDNA for tagmentation (0.1 ng/µl) yielding n = 12−15 cells per condition (Supplementary Fig. 2b) . We processed cells with sufficient cDNA into libraries for sequencing by tagmentation, however, samples from only one experiment of Fixed/TL samples were processed for sequencing, and we used the entire sample for library generation due to low cDNA yield. We included all sequenced single hESCs for analysis after subsampling to five million reads per cell. Importantly, the failure rate of live cells verses fixed cells is comparable.
For sequencing single human cortex progenitors (Figs. 4  and 5, and Supplementary Figs. 5−8) , we sorted 207 total SP cells from across four brains and 48 single SPE cells from across two brains for library preparation and all were sequenced. Of these, cells with more than 10,000 mapped reads, >20% reads mapping to mRNA, and detectable GAPDH expression were included in further analysis (157 SP and 29 SPE cells analyzed), all reads are included in analysis.
For analysis of human cortex by ICC, in Figure 6e we stained six brains and excluded one because of poor staining (n = 5 total analyzed), in Figure 6f we stained six brains and analyzed all, in Figure 6g we stained ten brains and excluded one due to poor staining (n = 9 total analyzed), in Figure 6h we stained nine brains and analyzed all, in Supplementary Figure 12a we stained four brains and excluded one due to poor staining (n = 3 total analyzed), and in Supplementary Figure 12b ,c we stained four brains and analyzed all.
Power analysis and statistical tests. In Figure 2b ,c prospective power for the comparisons was 1.0 given effect size = 5 × s.d. (about twofold change), n = 28 total samples, and α = 0.05.
In Figure 3d we used one-way ANOVA followed by Tukey's post-hoc test for the indicated comparisons. Data within each group followed normal distributions as indicated by Shapiro-Wilk test. Prospective power for the comparisons were 0.99-1.0 given effect size = 1−9 × s.d. (about twofold changes), n = 44 total samples, and α = 0.05.
In Figure 6e , we used Wilcoxon rank sum test because SOX2 + HOPX − data did not follow a normal distribution by the Shapiro-Wilk test. Prospective power for this comparison was 0.98 given effect size = 3 × s.d. (about twofold change), n = 5 brains per group, and α = 0.05.
For Figure 6f prospective power for the comparisons was 1.0 given effect size = 5 × s.d. (about twofold change), n = 5 brains per group, and α = 0.05. We conducted all power analyses using G*Power 42 .
